Latest Breaking News On - St pharm co ltd - Page 1 : comparemela.com

The South Korean market has recently experienced a slight downturn, dropping 1.3% over the last week, though it remains up by 5.6% over the past year with earnings expected to grow by 28% annually. In this context, stocks of growth companies with high insider ownership can be particularly appealing as they often reflect a commitment from those who know the company best, aligning their interests closely with other shareholders especially in promising market conditions.

South koreaSouth koreanJeisys medical incSt pharm co ltdCompanies with high insider ownershipSimply wall st growth ratingWall st growth ratingJeisys medicalMedical incFast growingWith high insider ownership